WEC
TMO icon

Winslow Evans & Crocker’s Thermo Fisher Scientific TMO Stock Holding History

Winslow Evans & Crocker’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$8.03M Buy
19,794
+1,622
+9% +$761K 1.52% 8
2020
Q3 		$8.02M Buy
18,172
+1,191
+7% +$492K 1.99% 7
2020
Q2 		$6.15M Sell
16,981
-5
-0% -$1.68K 1.64% 8
2020
Q1 		$4.82M Buy
16,986
+38
+0.2% +$12K 1.59% 8
2019
Q4 		$5.51M Buy
16,948
+610
+4% +$185K 1.4% 12
2019
Q3 		$4.76M Sell
16,338
-980
-6% -$281K 1.33% 13
2019
Q2 		$5.09M Buy
17,318
+20
+0.1% +$5.51K 1.42% 10
2019
Q1 		$4.74M Buy
17,298
+470
+3% +$117K 1.34% 12
2018
Q4 		$3.77M Buy
16,828
+6,790
+68% +$1.59M 1.27% 14
2018
Q3 		$2.45M Buy
10,038
+5,576
+125% +$1.28M 0.74% 25
2018
Q2 		$926K Buy
4,462
+1,140
+34% +$242K 0.29% 83
2018
Q1 		$686K Buy
3,322
+44
+1% +$9.23K 0.22% 102
2017
Q4 		$622K Buy
3,278
+10
+0.3% +$1.92K 0.2% 119
2017
Q3 		$618K Sell
3,268
-943
-22% -$171K 0.2% 115
2017
Q2 		$715K Buy
4,211
+2,055
+95% +$345K 0.2% 118
2017
Q1 		$331K Hold
2,156
– – 0.1% 205
2016
Q4 		$304K Sell
2,156
-810
-27% -$119K 0.09% 224
2016
Q3 		$472K Buy
2,966
+170
+6% +$26.2K 0.14% 160
2016
Q2 		$413K Hold
2,796
– – 0.12% 169
2016
Q1 		$396K Sell
2,796
-136
-5% -$18.2K 0.12% 169
2015
Q4 		$416K Buy
2,932
+1,450
+98% +$193K 0.12% 185
2015
Q3 		$181K Sell
1,482
-114
-7% -$14.9K 0.06% 286
2015
Q2 		$207K Hold
1,596
– – 0.06% 301
2015
Q1 		$214K Hold
1,596
– – 0.06% 287
2014
Q4 		$200K Sell
1,596
-206
-11% -$25K 0.06% 286
2014
Q3 		$219K Buy
1,802
+736
+69% +$89.5K 0.06% 297
2014
Q2 		$126K Buy
1,066
+165
+18% +$19.4K 0.04% 332
2014
Q1 		$108K Buy
901
+255
+39% +$30.3K 0.04% 339
2013
Q4 		$72K Buy
+646
New +$64.2K 0.02% 454

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Winslow Evans & Crocker's TMO Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Thermo Fisher Scientific (TMO) stake by 8.9% in Q4 2020, buying an estimated $761K and bringing the position to 19,794 shares worth $8.03M. The position accounts for 1.52% of the portfolio, ranked #8.

Winslow Evans & Crocker first reported a position in TMO in Q4 2013 and has held it in 29 quarters since. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

  • Winslow Evans & Crocker held 19,794 shares of Thermo Fisher Scientific worth $8.03M as of Q4 2020.
  • Winslow Evans & Crocker bought 1,622 Thermo Fisher Scientific shares in Q4 2020, an estimated $761K.
  • Thermo Fisher Scientific made up 1.52% of Winslow Evans & Crocker's portfolio in Q4 2020, its #8 holding.
  • Winslow Evans & Crocker first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 29 quarters since.
  • 2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.